Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 96 sources its claims cite is checked for support yet.

Time to Decompression in Obstructive Urosepsis from Ureteral Calculi: Thresholds, Initial Diversion, and Early Biomarkers: A Systematic Review

Open access
Benea, Adela, Porav-Hodade, Daniel, Turaiche, Mirela, Rosca, Ovidiu, Lighezan, Daniel-Florin, Rachieru, Ciprian, Stanga, Livia, Ilie, Adrian Cosmin, Sarau, Oana Silvana, Sarau, Cristian Andrei · 2025 · Journal of Clinical Medicine

Abstract

Background/Objectives: Obstructive urosepsis mandates rapid source control, yet actionable time-to-decompression (TTD) thresholds and the influence of diversion route remain debated. This review synthesized evidence on TTD, early outcomes, and predictive biomarkers. Methods: Following PRISMA-2020, ten studies met eligibility: three large administrative cohorts and seven clinical series/trials comparing outcomes by TTD and/or initial decompression (retrograde stent [RUS] vs. percutaneous nephrostomy [PCN]) and reporting biomarkers. Results: Delays were consistently harmful. In a national cohort, a TTD of ≥ 2 days increased in-hospital mortality (adjusted OR, 1.29; 95% CI, 1.03–1.63). Another analysis showed mortality of 0.16% with ≤48 h vs. 0.47% when delayed (derived OR, 0.43; p = 0.044). Absence of decompression yielded the highest mortality (19.2% vs. 8.82%; OR, 2.6; 95% CI, 1.9–3.7). Septic shock remained frequent despite low crude mortality in clinical series: 20.8% and 33.3% across two cohorts. Post-decompression urosepsis occurred in 18.7% in a randomized study and was associated with pyonephrosis and higher procalcitonin (PCT). An ED cohort showed that earlier stenting reduced length of stay (≤6 h: 35.6 h vs. 71.6 h, p = 0.01; ≤10 h: 45.7 h vs. 82.4 h, p = 0.04). Modality effects were modest; one cohort reported higher ICU use with PCN vs. RUS (OR, 3.23; 95% CI, 1.24–8.41), likely reflecting confounding by indication. Conclusions: Across designs, timeliness—not device choice—was the dominant determinant of early outcomes. Biomarkers (notably, PCT) and imaging features can prioritize ultra-early decompression.

Checked 2026-11-18 · 1 reference not checked yet

Overview

CoChat Summary

TL;DR

This PRISMA-2020 systematic review of 10 studies found that in obstructive urosepsis from ureteral calculi, delayed or absent decompression was consistently associated with worse early outcomes, while initial diversion modality had a smaller and confounded effect. Biomarkers such as procalcitonin and imaging signs of pyonephrosis may help prioritize ultra-early drainage.

Key findings

  • Delays or omission of decompression were consistently harmful: in Haas, TTD ≥2 days increased in-hospital mortality (adjusted OR 1.29; 95% CI 1.03–1.63); in Blackwell, mortality was 0.16% with ≤48 h vs 0.47% when delayed (derived OR 0.43; p = 0.044); in Borofsky, absence of decompression yielded 19.2% vs 8.82% mortality (OR 2.6; 95% CI 1.9–3.7).
  • Septic shock and post-decompression urosepsis remained frequent despite low crude mortality in clinical series: Yamamoto reported 20.8% septic shock across drainage events with 2.0% mortality; Tambo reported 33% shock (23/69); Lu reported post-decompression urosepsis in 18.7% (28/150), associated with pyonephrosis and higher procalcitonin.
  • Modality effects were modest and likely confounded: Goldsmith reported higher ICU use with PCN vs RUS (OR 3.23; 95% CI 1.24–8.41), but PCN recipients had higher baseline acuity (APACHE II 15 vs 11; stone size 10 vs 7 mm); Faw found earlier stenting reduced length of stay (≤6 h: 35.6 h vs 71.6 h, p = 0.01; ≤10 h: 45.7 h vs 82.4 h, p = 0.04).
  • The review concludes that timeliness—not device choice—was the dominant determinant of early outcomes, and that biomarkers (notably PCT) plus imaging features can prioritize ultra-early decompression.

Methods

  • PRISMA-2020 systematic review with an OSF-registered protocol; PubMed/MEDLINE, Embase, and Scopus were searched from inception to 10 September 2025; 943 records were identified and 10 studies met eligibility (three large U.S. administrative cohorts and seven clinical series/trials).
  • Eligible studies enrolled adults with infected, obstructed ureteral stones and reported time to decompression (TTD) and/or initial decompression modality (retrograde ureteral stent [RUS] vs percutaneous nephrostomy [PCN]) with at least one prespecified clinical outcome; extracted data included mortality, septic shock, ICU use, length of stay, biomarkers, cultures, and imaging.
  • Because of heterogeneity in TTD definitions, sepsis criteria, and case mix, the authors prespecified a narrative synthesis without formal meta-analysis; risk of bias was assessed with RoB 2 and ROBINS-I.

Limitations

  • The authors state that evidence is dominated by observational cohorts and administrative databases prone to misclassification, residual confounding (including confounding by indication for PCN), and heterogeneous TTD definitions and sepsis criteria; the small number of studies per outcome precluded a robust random-effects meta-analysis, biomarker thresholds varied, and individual-patient data meta-analysis was not feasible.
  • The authors also state that some reports provided limited adjustment for illness severity and that modality comparisons were influenced by anatomy and baseline risk, so modality-related associations (e.g., higher ICU use with PCN) were interpreted as hypothesis-generating.
  • Evident from the text: the review includes only 10 studies, mostly observational, and several discussion claims about biomarkers, imaging, and post-drainage timing rely on external references rather than the included evidence base.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/jcm14238546

Cites

36 of 37 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 PRISMA flowchart.
Figure 1 PRISMA flowchart.CC BY · PubMed Central
Figure 2 Effect sizes (odds ratios) for mortality and ICU use plotted on a log10(OR) axis [17,18,19,25]; the vertical line indicates OR = 1 (no difference). ICU—intensive care unit; OR—odds ratio; PCN—percutaneous nephrostomy.
Figure 2 Effect sizes (odds ratios) for mortality and ICU use plotted on a log10(OR) axis [17,18,19,25]; the vertical line indicates OR = 1 (no difference). ICU—intensive care unit; OR—odds ratio; PCN—percutaneous nephrostomy.CC BY · PubMed Central
Figure 3 Event rates across studies [18,19,20,21,22,23,25].
Figure 3 Event rates across studies [18,19,20,21,22,23,25].CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 77 Not checked · 32 Own results and interpretations

66 more claims

Create a free account to see all 109 claims and to verify the 96 references still open.

See all claims — free account
  • It may state two separate claims as one. 28
  • Probably not a substantial claim. 17

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

2 of 2

Citations

Cites

Show all 36 references

Research works printed but not linked: 1

  1. Belyayeva, M., Leslie, S.W., and Jeong, J.M. (2025, October 14). Acute Pyelonephritis. [Updated 2024 Feb 28], StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK519537/.

Cited by

See all 5

Metadata

Authors
Benea, A., Porav-Hodade, D., Turaiche, M., Rosca, O., Lighezan, D.-F., Rachieru, C., Stanga, L., Ilie, A. C., Sarau, O. S., & Sarau, C. A.
Affiliations
  • Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
  • Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO)
  • Methodological and Infectious Diseases Research Center, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
  • Department V of Internal Medicine, Discipline of Hematology, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
  • Department I of Internal Medicine, Faculty of Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
Corresponding author
  • Stanga, Livia
  • Ilie, Adrian Cosmin
Venue
Journal of Clinical Medicine
Publisher
MDPI AG
Published
2025-12-02
Volume
14
Issue
23
Pages
8546
ISSN
2077-0383 (ISSN-L)
OpenAlex
W4417125345
Cited by
5
References
36
Citations by year
2026: 5
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
Victor Babes University of Medicine and Pharmacy Timisoara
Topics
  • Health Sciences › Medicine › Urology › Kidney Stones and Urolithiasis Treatments
  • Health Sciences › Medicine › Urology › Ureteral procedures and complications
  • Health Sciences › Medicine › Urology › Urinary Tract Infections Management
Keywords
ureteral stones, percutaneous nephrostomy, procalcitonin, septic shock, pyonephrosis, in-hospital mortality, length of hospital stay, early biomarkers, source control

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Time to Decompression in Obstructive Urosepsis from Ureteral Calculi: Thresholds, Initial Diversion, and Early Biomarkers: A Systematic Review. https://app.cochat.ai/papers/10.3390/jcm14238546
The paper
Benea, A., Porav-Hodade, D., Turaiche, M., Rosca, O., Lighezan, D.-F., Rachieru, C., Stanga, L., Ilie, A. C., Sarau, O. S., & Sarau, C. A. (2025). Time to Decompression in Obstructive Urosepsis from Ureteral Calculi: Thresholds, Initial Diversion, and Early Biomarkers: A Systematic Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14238546

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.